STU:83B (China)
Â
Shs Unitary 144A/Reg S
€
2.126
-0.11 (-4.79%)
Jul 6
Business Description
3SBio Inc
NAICS : 325411
SIC : 2834
ISIN : KYG8875G1029
Share Class Description:
STU:83B: Shs Unitary 144A/Reg STotal Employee Number:
6,109Compare
Compare
Traded in other countries / regions
01530.Hong KongTRSBF.USA83B.Germany IPO Date
2015-06-11Description
3SBio Inc is an investment holding company. It is a primary biotechnology company. The company is principally engaged in the development, production, marketing and sale of biopharmaceutical products in the People's Republic of China. The group has only one operating segment. It has presence in Chinese mainland, USA, Other countries/regions. The majority of revenue comes from USA. The core commercialized products of the group include several bio-pharmaceutical drugs, namely, TPIAO, recombinant human erythropoietin (rhEPO) products EPIAO and SEPO, Yisaipu and Cipterbin, and a small molecule drug, Mandi series of minoxidil drugs.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 7.39 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | 0.23 | |||||
Interest Coverage | 139.85 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 7.05 | |||||
Beneish M-Score | -2.31 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 39.9 | |||||
3-Year EBITDA Growth Rate | 63.6 | |||||
3-Year EPS without NRI Growth Rate | 63.5 | |||||
3-Year FCF Growth Rate | 103 | |||||
3-Year Book Growth Rate | 26.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | -26.09 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 69.09 | |||||
9-Day RSI | 65.57 | |||||
14-Day RSI | 60.32 | |||||
3-1 Month Momentum % | -40.36 | |||||
6-1 Month Momentum % | -41.62 | |||||
12-1 Month Momentum % | -38.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.13 | |||||
Quick Ratio | 4.9 | |||||
Cash Ratio | 4.38 | |||||
Days Inventory | 245.71 | |||||
Days Sales Outstanding | 25 | |||||
Days Payable | 57.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.29 | |||||
Dividend Payout Ratio | 0.07 | |||||
3-Year Dividend Growth Rate | 9.8 | |||||
Forward Dividend Yield % | 1.31 | |||||
5-Year Yield-on-Cost % | 1.23 | |||||
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | -3.53 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 92.4 | |||||
Operating Margin % | 60.08 | |||||
Net Margin % | 47.98 | |||||
EBITDA Margin % | 64.22 | |||||
FCF Margin % | 51.61 | |||||
OCF Margin % | 54.67 | |||||
ROE % | 43.59 | |||||
ROA % | 30.52 | |||||
ROIC % | 50.96 | |||||
3-Year ROIIC % | 275.35 | |||||
ROC (Joel Greenblatt) % | 179.47 | |||||
ROCE % | 46.73 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 7 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 4.83 | |||||
Forward PE Ratio | 16.42 | |||||
PE Ratio without NRI | 4.96 | |||||
Shiller PE Ratio | 19.69 | |||||
Price-to-Owner-Earnings | 4.86 | |||||
PEG Ratio | 0.13 | |||||
PS Ratio | 2.32 | |||||
PB Ratio | 1.52 | |||||
Price-to-Tangible-Book | 1.95 | |||||
Price-to-Free-Cash-Flow | 4.5 | |||||
Price-to-Operating-Cash-Flow | 4.25 | |||||
EV-to-EBIT | 2.75 | |||||
EV-to-Forward-EBIT | 12.85 | |||||
EV-to-EBITDA | 2.63 | |||||
EV-to-Forward-EBITDA | 5.77 | |||||
EV-to-Revenue | 1.69 | |||||
EV-to-Forward-Revenue | 2.76 | |||||
EV-to-FCF | 3.26 | |||||
Price-to-GF-Value | 1.34 | |||||
Price-to-Projected-FCF | 0.73 | |||||
Price-to-DCF (Earnings Based) | 0.17 | |||||
Price-to-DCF (FCF Based) | 0.15 | |||||
Price-to-Median-PS-Value | 0.56 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.2 | |||||
Price-to-Graham-Number | 0.65 | |||||
| Price-to-Net-Current-Asset-Value | 3.04 | |||||
| Price-to-Net-Cash | 4.01 | |||||
Earnings Yield (Greenblatt) % | 36.36 | |||||
FCF Yield % | 22.06 | |||||
Forward Rate of Return (Yacktman) % | 25.94 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
3SBio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2,143.435 | ||
| EPS (TTM) (€) | 0.416 | ||
| Beta | -0.3083 | ||
| 3-Year Sharpe Ratio | 0.61 | ||
| 3-Year Sortino Ratio | 1.39 | ||
| Volatility % | 63.1 | ||
| 14-Day RSI | 60.32 | ||
| 14-Day ATR (€) | 0.103376 | ||
| 20-Day SMA (€) | 1.82942 | ||
| 12-1 Month Momentum % | -38.59 | ||
| 52-Week Range (€) | 1.613 - 3.82 | ||
| Shares Outstanding (Mil) | 2,499.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
3SBio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
3SBio Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2026 | 2026-08-28 | In 52 days | ||
| HKD 0.250000 Cash Dividend | 2026-07-21 | In 14 days | ||
| General meeting for 2025 | 2026-06-25 10:00 | 1.79 (-1.42%) | ||
| Annual report for 2025 | 2026-04-29 | 2.37 (+0.62%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-30 | 2.54 (-1.55%) | ||
| Second quarter earnings results for 2025 | 2025-08-29 | 2.96 (+0.00%) | ||
| HKD 0.250000 Cash Dividend | 2025-07-21 | 3.30 (+0.00%) | ||
| General meeting for 2024 | 2025-06-25 10:00 | 2.44 (+0.00%) | ||
| Annual report for 2024 | 2025-03-25 | 1.23 (+0.82%) | ||
| Fourth quarter earnings results for 2024 | 2025-03-25 | 1.23 (+0.82%) |
Show
Entries
3SBio Inc Frequently Asked Questions
What is 3SBio Inc(STU:83B)'s stock price today?
The current price of STU:83B is €2.13. The 52 week high of STU:83B is €3.82 and 52 week low is €1.61.
When is next earnings date of 3SBio Inc(STU:83B)?
The next earnings date of 3SBio Inc(STU:83B) is 2026-08-28 Est..
Does 3SBio Inc(STU:83B) pay dividends? If so, how much?
The Dividend Yield %  of 3SBio Inc(STU:83B) is 1.29% (As of Today), Highest Dividend Payout Ratio of 3SBio Inc(STU:83B) was 0.24. The lowest was 0.07. And the median was 0.13. The  Forward Dividend Yield % of 3SBio Inc(STU:83B) is 1.31%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on 3SBio Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers